Publication dates

Stem Cell Industry, July 2014 Market Reports from Top Publishers

You might be interested in: medical equipment, therapeutics, cancer, more »


 
1-10 of about 200 reports for Stem Cell

Zhongyuan Union Stem Cell Bio-Engineering Corp

Zhongyuan Union Stem Cell Bio-Engineering Corp

  • $ 55
  • Company report
  • July 2014
  • by Wright Investors' Service

... Earnings, price/book, price/sales and 52-week price change) and financial position (long-term debt/equity). Also included for zhongyuan union stem cell bio-engineering corp are the company description, recent ...

Shanghai Jiaoda Onlly Co., Ltd.

Shanghai Jiaoda Onlly Co., Ltd.

  • $ 55
  • Company report
  • July 2014
  • by Wright Investors' Service

... Ltd. There is a textual review of the financial results of shanghai jiaoda onlly co., Ltd. Versus zhongyuan union stem cell bio-engineering corp, zhenxing biopharmaceutical & chemical inc and jiangsu ...

Cancer Stem Cells Drug Pipeline Update 2014

Cancer Stem Cells Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... There are 7 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 262 drugs. Cancer stem cells drug pipeline update lists all drugs and gives you a progress analysis ...

StemCells, Inc. (formerly CytoTherapeutics, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

StemCells, Inc. (formerly CytoTherapeutics, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • July 2014
  • by MarketLine

... Trend, deal types and geography-based deal activity.Highlights:this report includes stemcells, inc. (Formerly cytotherapeutics, inc.)'S contact information and business summary ...

International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • July 2014
  • by MarketLine

... International stem cell corporation - mergers & acquisitions (m&a), partnerships & alliances and investment report project synopsis:marketline's company mergers & acquisitions (m ...

International Stem Cell Corporation

International Stem Cell Corporation

  • $ 55
  • Company report
  • July 2014
  • by Wright Investors' Service

... Equity). Also included for international stem cell corporation are the company description, recent stock performance, profitability analysis, dividend analysis, and key data items (ticker, major industry, sub ...

Ophthalmics Partnering Terms & Agreements

Ophthalmics Partnering Terms & Agreements

  • $ 1 995
  • Industry report
  • July 2014
  • by Currentpartnering

... Screeningsmall moleculesstem cellstoxicity chapter 7 - ophthalmics dealmaking by therapeutic target 7.1. Introduction7.2. Deals by therapeutic target appendices appendix 1 ...

World Therapy: Critical Limb Ischemia – Pipeline Review, H1 2012

World Therapy: Critical Limb Ischemia – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

... Receives fda approval to begin clinical trial in us with erc stem cells 100may 19, 2011: aldagen announces publication of phase i/ii results for ald-301 in catheterization and cardiovascular ...

Stem Cells -- 6 Dimensional Assessment (Technical Insights)

Stem Cells -- 6 Dimensional Assessment (Technical Insights)

  • $ 6 500
  • Industry report
  • June 2014
  • by Frost & Sullivan

... Certain physiologic conditions they can be induced to become tissue or organ-specific cells with particular functions, thus serving as an internal repair system, dividing to replenish other cells. stem cell ...

ReNeuron Group plc (Symbol:RENE) SWOT Analysis, Strategy, Revenues and Profits

ReNeuron Group plc (Symbol:RENE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • June 2014
  • by Global Data

... Of patients left disabled by the effects of a stroke. Its ren009 stem cell therapy is developed as a treatment for critical limb ischaemia and ren003 programme for blindness-causing diseases of the retina ...

About 1 800 reports for Stem Cell

Download Unlimited Documents from Trusted Public Sources

Stem Cell Industry in Russian Federation

  • The Social Legitimation of Biomedical Technologies in Russia: Co...
  • January 2013
    21 pages
  • Stem Cell  

  • Russian Federat...  

View report >

1 Companies for Stem Cell

Read our Company Profiles


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.